Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E J de Koning

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Nederlands Tijdschrift Voor Geneeskunde|May 8, 2004
[Diabetes mellitus, but which type?]J B Hoekstra, E J de Koning
Nederlands Tijdschrift Voor Geneeskunde|February 27, 2004
[Diabetic nephropathy: the role of blood pressure and extra-cellular volume in its pathogenesis and treatment]B Braam, E J de Koning, E J Mees
Biochemistry|November 7, 1995
Effect of pH and insulin on fibrillogenesis of islet amyloid polypeptide in vitroS B Chargé, E J de Koning, A Clark
Kidney International|July 5, 2007
Peritubular endothelium: the Achilles heel of the kidney?T J Rabelink, D C Wijewickrama, E J de Koning
Diabetic Medicine : a Journal of the British Diabetic Association|August 1, 1991
Autoantibodies to islet amyloid polypeptide in diabetesA Clark, S M Yon, E J de Koning, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|January 1, 1996
Islet amyloid in type 2 (non-insulin-dependent) diabetesA Clark, S B Chargé, M K Badman, et al.
The Journal of Pathology|February 1, 1995
High prevalence of pancreatic islet amyloid in patients with end-stage renal failure on dialysis treatmentE J de Koning, K A Fleming, D W Gray, et al.
Diabetologia|May 1, 1993
Diabetes mellitus in Macaca mulatta monkeys is characterised by islet amyloidosis and reduction in beta-cell populationE J de Koning, N L Bodkin, B C Hansen, et al.
Biochemical Society Transactions|May 1, 1996
Islet amyloid polypeptide: actions and role in the pathogenesis of diabetesA Clark, S B Charge, M K Badman, et al.
Diabetologia|October 20, 1999
Amyloid fibril formation is progressive and correlates with beta-cell secretion in transgenic mouse isolated isletsD L MacArthur, E J de Koning, J S Verbeek, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Nederlands Tijdschrift Voor Geneeskunde|May 8, 2004
[Diabetes mellitus, but which type?]J B Hoekstra, E J de Koning
Nederlands Tijdschrift Voor Geneeskunde|February 27, 2004
[Diabetic nephropathy: the role of blood pressure and extra-cellular volume in its pathogenesis and treatment]B Braam, E J de Koning, E J Mees
Biochemistry|November 7, 1995
Effect of pH and insulin on fibrillogenesis of islet amyloid polypeptide in vitroS B Chargé, E J de Koning, A Clark
Kidney International|July 5, 2007
Peritubular endothelium: the Achilles heel of the kidney?T J Rabelink, D C Wijewickrama, E J de Koning
Diabetic Medicine : a Journal of the British Diabetic Association|August 1, 1991
Autoantibodies to islet amyloid polypeptide in diabetesA Clark, S M Yon, E J de Koning, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|January 1, 1996
Islet amyloid in type 2 (non-insulin-dependent) diabetesA Clark, S B Chargé, M K Badman, et al.
The Journal of Pathology|February 1, 1995
High prevalence of pancreatic islet amyloid in patients with end-stage renal failure on dialysis treatmentE J de Koning, K A Fleming, D W Gray, et al.
Diabetologia|May 1, 1993
Diabetes mellitus in Macaca mulatta monkeys is characterised by islet amyloidosis and reduction in beta-cell populationE J de Koning, N L Bodkin, B C Hansen, et al.
Biochemical Society Transactions|May 1, 1996
Islet amyloid polypeptide: actions and role in the pathogenesis of diabetesA Clark, S B Charge, M K Badman, et al.
Diabetologia|October 20, 1999
Amyloid fibril formation is progressive and correlates with beta-cell secretion in transgenic mouse isolated isletsD L MacArthur, E J de Koning, J S Verbeek, et al.
Pageof 2